Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

Document Type : Original Article

Authors

Department of Rheumatology, El-Minia Faculty of Medicine

Abstract

Objective: To investigate whether serum levels of anti-Carbamylated antibodies are specifically 
elevated in active rheumatoid arthritis compared to clinical and laboratory markers of disease activity.
Methods: Sixty rheumatoid arthritis patients according to the ACR-EULAR criteria 2010 and 30 
matched healthy controls were recruited. Clinical evaluation of disease activity was measured by;
morning stiffness duration, Visual analogue scale, number of tender joints, number of swollen joints 
and DAS-28. Functional assessment was measured by the health assessment questionnaire (HAQ). 
Laboratory measures; ESR, CRP and RF titer was also done and finally radiological activity by 
ultrasound 7 score were determined parallel and correlated. Results: anti-Carbamylated antibody was
found to be positive in more than 50% of patients with active RA. Those patients were seronegative 
for RF. Anti-Carbamylated antibody positivity was significantly associated with duration of morning 
stiffness, number of tender joints, number of swollen joints, DAS28, HAQ DI, and acute phase 
reactants (ESR & CRP). Conclusion: Anti-CarP antibody was found to be positive in RA patients and 
it was significantly correlated with clinical, laboratory and radiological markers of disease activity as 
well as the functional assessment.

Keywords

Main Subjects

Minia Journal of Medical Research
Volume 31, Issue 2
April 2020
Pages 206-212

Files

Share

How to cite

Statistics